DA
APLT

Denali Advisors’s Applied Therapeutics APLT Stock Holding History

Denali Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,600
Closed -$228K – 195
2024
Q1 		$228K Buy
+33,600
New +$151K 0.07% 212
2022
Q1 		– Sell
-2,800
Closed -$25K – 380
2021
Q4 		$25K Buy
+2,800
New +$36.8K 0.01% 308

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Denali Advisors's APLT Position: Q2 2024 in Review

Denali Advisors sold out of Applied Therapeutics (APLT) in Q2 2024, closing a stake of 33,600 shares — an estimated $228K sold.

Denali Advisors first reported a position in APLT in Q4 2021 and held it in 2 quarters. The position peaked at $228K in Q1 2024. 94 funds tracked by Wall St. Rank hold APLT as of Q2 2024.

  • Denali Advisors reported no remaining Applied Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 33,600 Applied Therapeutics shares in Q2 2024, an estimated $228K.
  • Denali Advisors first reported a position in Applied Therapeutics in Q4 2021 and held it in 2 quarters.
  • Denali Advisors's Applied Therapeutics position peaked at $228K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.